What is the recommended approach to transfer a patient from hydromorphone (opioid analgesic) 4 mg to oxycodone (opioid analgesic)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting from Hydromorphone 4 mg to Oxycodone

When converting a patient from hydromorphone 4 mg to oxycodone, no washout period is required, but the dose should be reduced by 25-50% from the calculated equianalgesic dose to account for incomplete cross-tolerance. 1

Conversion Process

  1. Calculate total daily hydromorphone dose:

    • Determine the 24-hour hydromorphone requirement (e.g., 4 mg) 1
  2. Calculate equianalgesic oxycodone dose:

    • Using the conversion ratio of 1:5 (oral hydromorphone:oral oxycodone)
    • 4 mg oral hydromorphone = 20 mg oral oxycodone 1, 2
  3. Adjust for incomplete cross-tolerance:

    • Reduce the calculated equianalgesic dose by 25-50% 1
    • 20 mg oxycodone reduced by 25-50% = 10-15 mg oxycodone daily 1
  4. Determine dosing schedule:

    • Divide the total daily oxycodone dose by the number of doses per day 1
    • For immediate-release oxycodone: typically every 4-6 hours 3
    • For example: 10-15 mg daily ÷ 4 doses = 2.5-3.75 mg per dose 1

Important Clinical Considerations

  • No washout period needed: Direct conversion is appropriate as both are pure opioid agonists 1

  • Monitor closely: Especially during the first 24-72 hours after conversion for signs of under or overdosing 3

  • Breakthrough pain management: Provide short-acting opioid rescue doses (typically 10-15% of total daily dose) during transition 1

  • Individualized titration: After initial conversion, titrate dose based on pain control and side effects 3

  • Efficacy equivalence: Studies show hydromorphone and oxycodone have comparable efficacy and safety profiles when dosed appropriately 4, 5

Potential Pitfalls and Cautions

  • Avoid using fixed conversion ratios without clinical judgment: Patient variability means suggested doses are approximate 1

  • Consider patient-specific factors:

    • Age, renal/hepatic function, and comorbidities may affect dosing 3
    • CYP2D6 metabolism status can impact oxycodone efficacy 6
  • Avoid underdosing: If pain was poorly controlled on hydromorphone, consider using 100% of the equianalgesic dose or increase by 25% 1

  • Avoid overdosing: If transitioning due to side effects, use the lower end of the dose reduction range (50%) 1

  • Regular reassessment: Continually reevaluate pain control and adverse effects 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.